REEP2 and basal cell carcinoma: REEP2 was enriched in 12 items, with TOP 10 pathway as Graft Versus Host Disease, Allograft Rejection, Type I Diabetes Mellitus, Primary Immunodeficiency, Asthma, Basal Cell Carcinoma, Spliceosome, ECM Receptor Interaction, Wnt Signaling Pathway, Focal Adhesion (Figure 10c, Table 7, Table S23–24).